Dupuy Montana, Zhong Liezhou, Radavelli-Bagatini Simone, Via Jack Dalla, Zhu Kun, Blekkenhorst Lauren C, Webster James, Bondonno Nicola P, Linneberg Allan, Schultz Carl, Lim Wai, Prince Richard L, Hodgson Jonathan M, Lewis Joshua R, Sim Marc
Nutrition & Health Innovation Research Institute, School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.
School of Exercise and Nutrition Sciences, Deakin University, Geelong, Victoria, Australia.
Eur J Nutr. 2025 May 3;64(4):171. doi: 10.1007/s00394-025-03686-x.
Vitamin K may inhibit vascular calcification, a common attribute of atherosclerotic vascular diseases (ASVDs). We examined associations between dietary vitamin K1 intakes and both subclinical atherosclerosis and ASVD events, including hospitalisations and mortality, in older women.
1,436 community-dwelling women (mean ± SD age 75.1 ± 2.7 years) were included. Vitamin K1 intakes were calculated from a validated food frequency questionnaire at baseline (1998), utilising a region-matched vitamin K food database. Common carotid artery intima-media thickness (CCA-IMT), a measure of subclinical atherosclerosis, was measured in 2001 (n = 1,090). Differences in CCA-IMT by quartiles (Q) of vitamin K1 intake were examined using multivariate analysis of variance. Associations between vitamin K1 intakes and ASVD outcomes (hospitalisations and/or deaths), obtained from linked health records over 14.5 years, were analysed using restricted cubic splines within multivariable-adjusted Cox-proportional hazard models.
Women with higher vitamin K1 intakes had a 5.6% lower mean CCA-IMT (Q4 [median 119 µg/day] compared to Q1 [median 49 µg/day], p < 0.001). Over 14.5 years, 620 (43.1%), 497 (34.6%) and 301 (20.9%) ASVD events, hospitalisations, and deaths were recorded, respectively. In multivariable-adjusted models, the highest vitamin K1 intakes (Q4, compared to Q1), were associated with lower relative hazards for ASVD events (HR 0.71 95%CI 0.55-0.92) and ASVD mortality (HR 0.57 95%CI 0.40-0.83), but not ASVD hospitalisations (HR 0.83 95%CI 0.63-1.11).
Vitamin K1 intakes of ~ 120 µg/day appear to be beneficial in lowering risk for subclinical and clinical ASVD in older women. These quantities can be attained by consuming vitamin K1 rich foods, such as leafy green vegetables.
维生素K可能抑制血管钙化,这是动脉粥样硬化性血管疾病(ASVD)的一个常见特征。我们研究了老年女性饮食中维生素K1摄入量与亚临床动脉粥样硬化及ASVD事件(包括住院和死亡)之间的关联。
纳入1436名社区居住女性(平均年龄±标准差为75.1±2.7岁)。维生素K1摄入量通过1998年基线时一份经过验证的食物频率问卷计算得出,使用的是区域匹配的维生素K食物数据库。2001年测量了200名女性(n = 1090)的颈总动脉内膜中层厚度(CCA-IMT),这是亚临床动脉粥样硬化的一个指标。通过方差多变量分析研究维生素K1摄入量四分位数(Q)之间CCA-IMT的差异。利用多变量调整的Cox比例风险模型中的受限立方样条分析维生素K1摄入量与14.5年期间从关联健康记录中获得的ASVD结局(住院和/或死亡)之间的关联。
维生素K1摄入量较高的女性平均CCA-IMT低5.6%(与第一四分位数[中位数49μg/天]相比,第四四分位数[中位数119μg/天],p < 0.001)。在14.5年期间,分别记录了620例(43.1%)、497例(34.6%)和301例(20.9%)ASVD事件、住院和死亡。在多变量调整模型中,最高的维生素K1摄入量(第四四分位数与第一四分位数相比)与ASVD事件(风险比0.71,95%置信区间0.55 - 0.92)和ASVD死亡率(风险比0.57,95%置信区间0.40 - 0.83)的相对风险较低相关,但与ASVD住院(风险比0.83,95%置信区间0.63 - 1.11)无关。
每天摄入约120μg的维生素K1似乎有助于降低老年女性亚临床和临床ASVD的风险。通过食用富含维生素K1的食物,如绿叶蔬菜,可以达到这些摄入量。